Background: Hepatitis is a serious blood born infection in patients with β-thalassemia major (β-TM). There was no previous report on hepatitis prevalence in patients with β-TM in Zabol, Iran. Objectives: The current study aimed to evaluate characteristics of hepatitis in patients with β-TM visiting Imam Khomeini Hospital
Background
Thalassemia constitutes a major general-health problem in Iran (1, 2) , and β-thalassemia major (β-TM) is the most common cause of thalassemia major in Iranians. In addition to psychological and financial burdens, encountering adverse effects of transfusion therapy represents a dilemma for patients with β-TM and their families. Accordingly, transmission of hepatitis infections renders as concerning sequel of repeated transfusions in patients with β-TM (3) . In fact, hepatitis is responsible for a large spectrum of liver dysfunctions including hepatic enzymes abnormalities, hepatic fibrosis and cirrhosis (4, 5) .
Relatively high frequencies of both β-TM and hepatitis are reported in Sistan and Baluchistan province (2, 6) .
Therefore, patients with β-TM are at significantly high risk of being infected with hepatitis through transfusion of donated blood units. Despite this fact, there is no report on frequency and features of hepatitis infection in transfusion dependent patients with β-TM in Zabol.
Objectives
The current study aimed to evaluate the seroepidemiology and clinical significance of anti-HCV, HBs antigen and anti-HBs in patients with β-TM seeking medical care in Imam Khomeini Hospital of Zabol.
Materials and Methods
This descriptive cross-sectional study was carried out in 2014. Consent form was signed by the patients or their parents before entering into the study. Authors interviewed and checked clinical records of 90 patients with β-TM regularly visiting Imam Khomeini hospital of Zabol to obtain demographic and general laboratory data.
Positivity for anti-HCV, HBs antigen and anti-HBs were determined using latest clinical records of the patients. Subsequently, data were transferred into SPSS ver.19 software; and then descriptive and inferential statistical analyses were carried out using Chi-square test, standard indeCopyright © 2016, Qazvin University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. pendent sample t-test, one-way ANOVA and logistic regression for the intended variables.
Results
Distribution of two genders in the selected sample was 51% males and 49% females. Mean age of the patients was 14.8 ± 7.4 years old. Mean ferritin value was 4702 ± 2743 ng/mL; while mean serum values of aspartate transaminase (AST) and alanine transaminase (ALT) enzymes were measured 51.8 ± 32.8 IU/L and 58.8 ± 59 IU/L, respectively. Table 1 shows general features of the studied population including age groups and health status of spleen and liver. Anti-HCV was identified in nine out of 90 patients (10%), and HBs antigen was positive in three (3.3%) patients. Regarding anti-HBs, 68 (75.6%) subjects were immune (antibody titer > 10 IU), 14 (15.6%) were non-immune (antibody titer 2 -10 IU), and 8 (8.9%) had negative results (antibody titer < 2 IU). Significant association was observed between anti-HCV positivity and both age and spleen condition of the patients (respective p values of 0.01 and 0.05, Table 2 ). Mean age of anti-HCV positive patients was higher (20.1 ± 3.6) than negative individuals (14.2 ± 7.5, P = 0.02, Table   3 ). Although mean serum levels of AST and ALT hepatic enzymes were also higher in anti-HCV positive patients, the difference was not statistically significant. Moreover, no association was observed between anti-HBs or HBs antigen status and demographical or clinical parameters. Furthermore, serum ferritin level was significantly correlated with age of the patients (P = 0.01). Mean value of ferritin was significantly higher in patients > 10 years old 2
Biotech Health Sci. 2016; 3(2):e35687. compared to that of the patients < 10 years old; however, the differences of mean values of hepatic enzymes were not of statistically significant in different age groups (Table  3 ). In addition, significant difference of mean ferritin value was noticed regarding spleen status (Table 4 ). In contrast, mean levels of hepatic enzymes were not statistically different regarding either spleen or liver conditions. Tables  3 and 4 represent stratified description of mean age, ferritin and hepatic enzymes regarding anti-HCV status, and spleen or liver conditions.
Discussion
Successive long-term transfusions expose patients with β-TM to the risk of infections with a wide range of pathogens including hepatitis. In recent decade, effective vaccination and screening procedures resulted in remarkable reduction in hepatitis B virus (HBV) transmission through blood products. However, hepatitis C virus (HCV) is still encountered in a relatively high ratio of blood recipients (7). HCV is responsible for 90% of transfusion related non-A and non-B hepatitis infections worldwide (8) . It is estimated that 3% of the world population are exposed to HCV virus (9) . Furthermore, HCV infection may cause a complicated situation in patients with β-TM through aggravation of iron-induced organ damage (10) . It is mentioned that some current anti-viral treatments against HCV infection can induce RBC hemolysis, which accentuate iron overload (11) . On the other hand, HCV infection and iron toxicity may cooperate to accelerate development of chronic liver abnormalities such as fibrosis and cirrhosis in patients with β-TM (8, 10, 12) . Anti-HCV was detected in 10% of the patients with β-TM in the current study. It was lower than the ratio described in some previous studies in North of the country (13, 14) , but similar to the rate obtained in the study performed on Iranian patients by Tamaddoni et al. (15) . Higher incidence of HCV infection in the northern regions may be partly due to high ratio of individuals with HCV infection harboring in general population of the areas (16) . Furthermore, positivity for anti-HCV was as high as 33% in studies conducted on Iranian patients with thalassemia major before 2000; however, this ratio was reported to have decreased to 15% -19% in recent years (6) . In other studies on Iranian patients, anti-HCV was described in range of 6% -8% in patients with thalassemia (17, 18) . Moreover, in the studies carried out in Thailand (8) and Jordan (19), anti-HCV frequencies were 20% and 40% respectively in patients with thalassemia. Collectively, these results indicate the efficiency of blood donor screening programs in decreasing transmission of HCV infection over the past decade in Iran.
However, more sophisticated strategies should be implemented to minimize the risk of transmission of infections by blood transfusion.
In the current study, anti-HCV positivity was significantly associated both with age and spleen condition of the patients (Table 1) . Patients with positive results for anti-HCV were older than the ones with negative results by a mean difference of six years ( vious study in Iran also demonstrated that anti-HCV positive patients were significantly older compared to anti-HCV negative ones (20) . Similarly, patients who had anti-HCV-positive results were significantly older than anti-HCV-negative ones in a study carried out in Oman (21). In addition, previous studies suggested the HCV infection as a strongly age dependent complication in patients with β-TM (22) . Therefore, it is beneficial to consider performing regular occasional screenings for HCV infection especially in older patients with β-TM.
In addition, spleen condition is suggested as a risk factor associated with HCV infection in patients with β-TM.
Results of the current study also supported this hypothesis since a significant relationship was observed between spleen status and anti-HCV positivity. On the contrary, Ahmad Akbari et al. found no association between spleen state and HCV positivity in a study on the Iranian patients with thalassemia major and intermediate (23) . Nevertheless, it seems that splenectomy may potentially boost the risk of HCV infection in higher ages; therefore, it is recommended to postpone this procedure as long as possible in patients with β-TM.
Additionally, it was also observed that serum ferritin level was higher in anti-HCV positive patients with β-TM (Table 2) ; however, the difference was not statistically significant (P > 0.05). In parallel, serum ferritin level was significantly higher in anti-HCV positive patients with β-TM in a systemic multivariate analysis in Iran (7). Nevertheless, ferritin value is also highly dependent on different factors including efficacy of chelation therapy which should be considered when studying the effects of HCV infection on ferritin level.
It is established that HCV infection also contributes in liver dysfunction and deranged levels of hepatic enzymes. Although mean levels of hepatic enzymes were higher in anti-HCV positive patients in the current study (Table 2) , the difference was statistically insignificant. In another study in Iran, also no association was detected between the level of hepatic enzymes and HCV infection (14) . In comparison, anti-HCV positive patients had significantly higher AST and ALT levels in a study on Thai patients (8) . Considering intercalated relationships between hepatic function and both HCV infection and iron-burden of liver; more studies are necessitated in order to establish the role of these factors in pathogenesis of liver dysfunction in β-TM.
Frequency of HBs antigen positivity was 3.3%% in the current study. This was higher than the results recorded by Wanachiwanawin et al. (8) and Karimi et al. (24) . On the other hand, the current study results showed lower prevalence in comparison to a study carried out on Indian patients (25) . Regardless of the above mentioned facts, high prevalence of HBs antigen positivity in the current study patients highlights requirements for more intense screening procedures to minimize the ratio as much as possible. Reactivity for anti-HBs occurred in a high proportion (91%) of the patients evaluated in the present study. Accordingly, negative HBs antigen results and also lack of previous vaccination in majority of anti-HBs positive patients raise the challenges regarding the source of these antibodies. It is suggested that these antibodies may be passively transmit-ted from immunized blood donors. This phenomenon is plausible because of the vaccination programs performed on normal Iranian populations in past years (26).
Conclusions
Considering the high rate of HCV infection in the present study, it is recommended to screen the patients with appropriate tests on a routine basis. Regarding the lower rate of HBs antigen positivity, it seems that reactivity of anti-HBs, especially in younger patients, originates from passively transmitted antibodies rather than true infection; however, cautious vaccination is appropriate in such patients.
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